Exact Mass: 329.1223

Exact Mass Matches: 329.1223

Found 4 metabolites which its exact mass value is equals to given mass value 329.1223, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

5,6-Dihydro-5-azathymidine- 3,5-Di-O-Ac

5,6-Dihydro-5-azathymidine- 3,5-Di-O-Ac

C13H19N3O7 (329.1223)


   

5-AZIDO-5-DEOXY-3,4-DI-O-ACETYL-1,2-O-ISOPROPYLIDENE-BETA-D-FRUCTOSE

5-AZIDO-5-DEOXY-3,4-DI-O-ACETYL-1,2-O-ISOPROPYLIDENE-BETA-D-FRUCTOSE

C13H19N3O7 (329.1223)


   

4-Cyano-3,5-Difluorophenyl 4-Pentyl-Benzoate

4-Cyano-3,5-Difluorophenyl 4-Pentyl-Benzoate

C19H17F2NO2 (329.1227)


   

Molnupiravir

Molnupiravir

C13H19N3O7 (329.1223)


J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AB - Nucleosides and nucleotides excl. reverse transcriptase inhibitors COVID info from DrugBank, clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C254 - Anti-Infective Agent > C281 - Antiviral Agent > C190794 - SARS-CoV-2 Antiviral Agent D000890 - Anti-Infective Agents > D000998 - Antiviral Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Molnupiravir (EIDD-2801) is an orally bioavailable proagent of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity against influenza virus and multiple coronaviruses, such as SARS-CoV-2, MERS-CoV, SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza[1][2].